labcorp america lh
lh share trade lower report revenu growth
street covanc outperform diagnost busi
under-perform on-going ep miss street manag lower
revenu ep midpoint adjust model downward
number item trim ep
remain overweight target fall unchang multipl
result labcorp report yoy cc revenu increas
street estim adjust diagnost increas exclud
previous announc malwar disrupt hurrican florenc adjust
cc street estim adjust divestitur
volum increas consist organ pjc acquisit
volum pjc rev/req decreas estim
covanc grew cc better street estim
primarili due acquisit chiltern solid core organ growth
margin improv covanc declin diagnost yield
declin overal oper margin vs consensu
on-going ep miss street estim
busi updat broad-bas success covanc lead trail book-
to-bil backlog sequenti
manag mention quest alreadi target larger
revenu growth dx flat-to-down covanc modest earn growth
includ impact share repurchas manag alreadi outlin gener
unh/aet expect impli net price would like off-set pama
opinion volum difficult predict comment suggest signific
reacceler annual unh/aet impact earli
guidanc manag lower revenu ep midpoint
tighten rang previou quarter current guidanc ep
previous reflect previous mention busi
disrupt revenu guidanc mid
point reflect bp lower fx benefit bpt bpt bp
busi disrupt suggest bpt lower volum diagnost growth
lower midpoint wherea covanc rais
recogn labcorp current challeng believ combin
stabl diagnost improv covanc lead long-term out-performance
risk includ slower volum growth reimburs pressur competit
labcorp lead provid clinic diagnost laboratori servic
intra-day price
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
laboratori corpor america hold
page
servic
amort intang
equiti earn affili
labcorp america hold nyse lh
us million except note
non-recur item net tax
bad debt expens rev
servic
bad debt clinic lab
debt ebitda
compani report piper jaffray co current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
